Bailey H. Duhon

Mr. Bailey H. Duhon

Texas A&M University, College Station, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BDBailey H. Duhon
Bailey H. Duhon
TPThien T. Phan
Thien T. Phan
STShannon L. Taylor
Shannon L. Taylor
RCRachelle Crescenzi
Rachelle Crescenzi
JRJoseph M. Rutkowski
Joseph M. Rutkowski
Lymphedema and lipedema are complex diseases. While the external presentation of swollen legs in lower-extremity lymphedema and lipedema appear similar, current mechanistic understandings of these diseases indicate unique aspects of their underlying pathophysiology. They share certain clinical features, such as fluid (edema), fat (adipose expansion), and fibrosis (extracellular matrix remodeling). Yet, these diverge on their time course and known molecular regulators of pathophysiology and genetics. This divergence likely indicates a unique route leading to interstitial fluid accumulation and subsequent inflammation in lymphedema versus lipedema. Identifying disease mechanisms that are causal and which are merely indicative of the condition is far more explored in lymphedema than in lipedema. In primary lymphedema, discoveries of genetic mutations link molecular markers to mechanisms of lymphatic disease. Much work remains in this area towards better risk assessment of secondary lymphedema and the hopeful discovery of validated genetic diagnostics for lipedema. The purpose of this review is to expose the distinct and shared (i) clinical criteria and symptomatology, (ii) molecular regulators and pathophysiology, and (iii) genetic markers of lymphedema and lipedema to help inform future research in this field.

12 February 2026 in Journal of Neuroscience Methods
Verified
Journal Article
Open access
BDBailey H. Duhon
Bailey H. Duhon
MFMelanie Fisher
Melanie Fisher
HNHan Tn. Nguyen
Han Tn. Nguyen
MRMatthew T. Rocco
Matthew T. Rocco
EBEric C. Bielefeld
Eric C. Bielefeld
YRYin Ren
Yin Ren
Sensorineural hearing loss (SNHL) is the most common symptom of vestibular schwannoma (VS), arising from multifactorial tumor-host interactions including mechanical cochleovestibular nerve compression and ototoxic tumor secretion, yet underlying mechanisms remain incompletely defined. This study establishes an anatomically precise mouse model and investigates the role of blood-labyrinth barrier (BLB) disruption in VS-associated SNHL. Adapting neuro-otologic surgical techniques, a petrosectomy with lateral semicircular canal fenestration was used to implant mouse Nf2-/- Schwann cells and patient-derived primary VS cells into the cochleovestibular nerve within the internal auditory canal (IAC). Tumor growth was assessed by MRI and bioluminescence, while auditory and vestibular functions were evaluated by auditory brainstem response and behavioral assays. Immunofluorescence of inflammatory, matrix-remodeling, and tight junction markers were performed in the tumor, brainstem and cochlea. VS allografts progressed from the IAC to the cerebellopontine angle, exhibiting mixed Antoni A/B architecture. Auditory and vestibular function was preserved postoperatively and progressively declined with tumor growth. Macrophage/microglia activation was observed in the tumor, brainstem and cochleovestibular nerve. Matrix metalloprotease-9 (MMP-9) and high mobility group box 1 (HMGB1) overexpression in the tumor and ipsilateral cochlea was associated with evidence of BLB disruption, characterized by tight junction downregulation and significant vascular disorganization in the stria vascularis. Existing animal models either require months to develop or fail to recapitulate native VS progression and hearing decline. This novel mouse model recapitulates native VS progression within the IAC and offers a powerful platform to investigate mechanisms underlying VS-associated SNHL.